⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 12, 2024Open Access

Table S1 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy

Ignacio Campillo‐Marcos Marta Casado-Peláez Verónica Dávalos Gerardo Ferrer Caterina Mata Elisabetta Mereu Gaël Roué David Valcárcel Antonieta Molero Lurdes Zamora Blanca Xicoy Laura Palomo Pamela Acha Ana Manzanares Magnus Tobiasson Eva Hellström‐Lindberg Françesc Solé Manel Esteller

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Clinicopathologic information of the studied MDS patients

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Campillo‐Marcos et al. (2024) studied this question.

synapsesocial.com/papers/68e79856b6db64358770927e https://doi.org/10.1158/2767-9764.25206425.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S1 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024
2TABLE 1 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024
3TABLE 1 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024
4Table S6 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024
5Table S6 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024

More related papers

Figure S4 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024
Table S5 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024
Table S5 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024